Cargando…

Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy

BACKGROUND: Lenvatinib is a novel tyrosine kinase inhibitor that exhibits an antitumor effect on hepatocellular carcinoma (HCC). An established strategy that involves surgery and usage of lenvatinib for advanced HCC remains elusive. CASE PRESENTATION: A 58-year-old male patient with advanced HCC and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohya, Yuki, Hayashida, Shintaro, Tsuji, Akira, Kuramoto, Kunitaka, Shibata, Hidekatsu, Setoyama, Hiroko, Hayashi, Hironori, Kuriwaki, Kazumi, Sasaki, Masato, Iizaka, Masayoshi, Nakahara, Osamu, Inomata, Yukihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7728870/ https://www.ncbi.nlm.nih.gov/pubmed/33301055 http://dx.doi.org/10.1186/s40792-020-01078-3

Ejemplares similares

A case of Trousseau’s syndrome due to intrahepatic cholangiocarcinoma with an extremely high level of CA19-9
por: Sasaki, Ryosuke, et al.
Publicado: (2020)

Laparoscopic surgery for two patients with strangulated transomental hernias
por: Fujimoto, Yuka, et al.
Publicado: (2020)

Laparoscopic intervention for late-onset perforating peritonitis due to a ventriculoperitoneal shunt: a case report and literature review
por: Morinaga, Takeshi, et al.
Publicado: (2023)

Single incision laparoscopic surgery (SILS) for Meckel’s diverticulum
por: Kuramoto, Kunitaka, et al.
Publicado: (2019)

Incarceration of a colonoscope in an inguinal hernia: A report of two cases
por: Abe, Yuno, et al.
Publicado: (2022)

Trousseau syndrome with intrahepatic cholangiocarcinoma that could be removed radically after endovascular treatment: Report of a case
por: Murahashi, Shuei, et al.
Publicado: (2020)

Hepatic and portal vein transection by vascular stapler in open living donor hepatectomy – A retrospective cohort study
por: Obed, Doha, et al.
Publicado: (2022)

Adult Living Donor Liver Transplantation for Patients With Portal Vein Thrombosis: A Single-center Experience
por: Miura, Kohei, et al.
Publicado: (2018)

Conversion hepatectomy for hepatocellular carcinoma with main portal vein tumour thrombus after lenvatinib treatment: A case report
por: Takahashi, Kazuhiro, et al.
Publicado: (2021)

Liver transplantation for a patient with Turner syndrome presenting severe portal hypertension: a case report and literature review
por: Kawabata, Seiichi, et al.
Publicado: (2016)

Right hepatectomy using Glissonean pedicle transection method with anterior approach (with video)
por: Katagiri, Satoshi, et al.
Publicado: (2011)

The Safety Profile of Hepatectomy Following Preoperative Systemic Therapy with Lenvatinib Plus Anti-PD-1 Antibodies Versus Hepatectomy Alone in Patients With Hepatocellular Carcinoma
por: Shen, Ying-Hao, et al.
Publicado: (2022)

Survival Benefits From Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma and Microvascular Invasion After Curative Hepatectomy
por: Dai, Mu-Gen, et al.
Publicado: (2023)

When should endovascular gastrointestinal anastomosis transection Glissonean pedicle not be used in hepatectomy? A case report
por: Zhao, Jian, et al.
Publicado: (2022)

Analysis of Lenvatinib’s Efficacy against Intermediate-Stage Unresectable Hepatocellular Carcinoma
por: Amioka, Kei, et al.
Publicado: (2022)

Evaluating the Effect of Lenvatinib on Sorafenib-Resistant Hepatocellular Carcinoma Cells
por: Shi, Tingting, et al.
Publicado: (2021)

Therapeutic Efficacy and Safety of Lenvatinib after Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma
por: Yano, Shigeki, et al.
Publicado: (2023)

Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy
por: Ohya, Kazuki, et al.
Publicado: (2019)

Analysis of Survival and Response to Lenvatinib in Unresectable Hepatocellular Carcinoma
por: Amioka, Kei, et al.
Publicado: (2022)

Effect of Lenvatinib treatment on the cell cycle and microRNA profile in hepatocellular carcinoma cells
por: Nakahara, Mai, et al.
Publicado: (2022)

Long-term Outcomes of ABO-incompatible Pediatric Living Donor Liver Transplantation
por: Honda, Masaki, et al.
Publicado: (2018)

Transection Speed and Impact on Perioperative Inflammatory Response – A Randomized Controlled Trial Comparing Stapler Hepatectomy and CUSA Resection
por: Schwarz, Christoph, et al.
Publicado: (2015)

Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis
por: Hiraoka, Atsushi, et al.
Publicado: (2018)

New classification‐oriented treatment strategy for portal vein thrombosis after hepatectomy
por: Onda, Shinji, et al.
Publicado: (2020)

Impact of Grip Strength in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib
por: Endo, Kei, et al.
Publicado: (2020)

A case of Vp4 hepatocellular carcinoma with tumor thrombosis extending into the confluence of the splenic/portal vein achieved a good prognosis with emergent hepatectomy and postoperative adjuvant therapy with lenvatinib
por: Kato, Hiroyuki, et al.
Publicado: (2022)

Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis
por: Ouyang, Jingzhong, et al.
Publicado: (2023)

Clamp-Crushing versus stapler hepatectomy for transection of the parenchyma in elective hepatic resection (CRUNSH) - A randomized controlled trial (NCT01049607)
por: Rahbari, Nuh N, et al.
Publicado: (2011)

Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis
por: Hiraoka, Atsushi, et al.
Publicado: (2019)

Appropriate indications for laparoscopic repeat hepatectomy
por: Masuda, Takashi, et al.
Publicado: (2023)

Case report: Hepatectomy with Rex bypass for a child with hepatoblastoma and portal vein thrombosis
por: Kitagawa, Norihiko, et al.
Publicado: (2023)

Successful Treatment by Surgery and Lenvatinib of a Patient with Adrenal Metastasis of Papillary Thyroid Cancer
por: Nakamura, Hajime, et al.
Publicado: (2020)

Lenvatinib combined nivolumab injection followed by extended right hepatectomy is a feasible treatment for patients with massive hepatocellular carcinoma: a case report
por: Chen, Xin, et al.
Publicado: (2019)

Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab
por: Yano, Shigeki, et al.
Publicado: (2021)

Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma
por: Kuorda, Hidekatsu, et al.
Publicado: (2019)

Lenvatinib for poorly differentiated carcinoma of the anterior mediastinum
por: Yanagihara, Toyoshi, et al.
Publicado: (2021)

Therapeutic efficacy of lenvatinib in nonviral unresectable hepatocellular carcinoma
por: Tomonari, Tetsu, et al.
Publicado: (2021)

Objective Response by mRECIST to Initial Lenvatinib Therapy Is an Independent Factor Contributing to Deep Response in Hepatocellular Carcinoma Treated with Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy
por: Kuroda, Hidekatsu, et al.
Publicado: (2022)

Destructive Thyroiditis Induced by Lenvatinib in Three Patients with Hepatocellular Carcinoma
por: Hirooka, Masashi, et al.
Publicado: (2018)

Lenvatinib for large hepatocellular carcinomas with portal trunk invasion: Two case reports
por: Komiyama, Satoshi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_o3a86v3s4p9b64rvkpbub3tdpq